The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing
- 7 June 2005
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 112 (10) , 1369-1375
Abstract
Objective To assess the implications of a change in prenatal diagnosis policy from full karyotype analysis to rapid trisomy testing for women referred primarily for increased risk of Down's Syndrome.Design Retrospective collection and review of data.Setting The four London Regional Genetics Centres.Population Pregnant women (32,674) in the London area having invasive prenatal diagnosis during a six‐year three‐month period.Methods Abnormal karyotypes and total number of samples referred for raised maternal age, raised risk of Down's Syndrome following serum screening or maternal anxiety were collected. Abnormal karyotypes detected by molecular trisomy detection were removed, leaving cases with residual abnormal karyotypes. These were assessed for their clinical significance. Pregnancy outcomes were ascertained by reviewing patient notes or by contacting obstetricians or general practioners.Main outcome measures Proportion of prenatal samples with abnormal karyotypes that would not have been detected by rapid trisomy testing, and the outcome of those pregnancies with abnormal karyotypes.Results Results from 32,674 samples were identified, of which 24,891 (76.2%) were from women referred primarily for Down's Syndrome testing. There were 118/24,891 (0.47%) abnormal sex chromosome karyotypes. Of the samples with autosomal abnormalities that would not be detected by rapid trisomy testing, 153/24,891 (0.61%) were in pregnancies referred primarily for Down's Syndrome testing. Of these, 98 (0.39%) had a good prognosis (46/98 liveborn, 3/98 terminations, 1/98 intrauterine death, 1/98 miscarriage, 47/98 not ascertained); 37 (0.15%) had an uncertain prognosis (20/37 liveborn, 5/37 terminations; 12/37 not ascertained) and 18 (0.07%) had a poor prognosis (1/18 liveborn, 2/18 miscarriage, 11/18 terminations, 4/18 not ascertained).Conclusions For pregnant women with a raised risk of Down's Syndrome, a change of policy from full karyotype analysis to rapid trisomy testing would result in the failure to detect chromosome abnormalities likely to have serious clinical significance in approximately 0.06% (1 in 1659) cases. However, it should be noted that this figure may be higher (up to 0.12%; 1 in 833) if there were fetal abnormalities in some of the pregnancies in the uncertain prognosis group for which outcome information was not available.Keywords
This publication has 26 references indexed in Scilit:
- Strategies for the rapid prenatal diagnosis of chromosome aneuploidyEuropean Journal of Human Genetics, 2004
- Deletion of the distal long arm of chromosome 10; is there a characteristic phenotype? A report of 15 de novo and familial casesAmerican Journal of Medical Genetics Part A, 2003
- Can Amnio–Polymerase Chain Reaction Alone Replace Conventional Cytogenetic Study for Women With Positive Biochemical Screening for Fetal Down Syndrome?Obstetrics & Gynecology, 2003
- Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational studyThe Lancet, 2001
- Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screeningPrenatal Diagnosis, 2001
- Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridisationBJOG: An International Journal of Obstetrics & Gynaecology, 2000
- Repeat maternal serum testing for down's syndrome screening using multiple markers with special reference to free α and free β-hCGPrenatal Diagnosis, 1995
- Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five‐colour fluorescence in situ hybridizationPrenatal Diagnosis, 1994
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986
- Chemical differentiation along metaphase chromosomesExperimental Cell Research, 1968